Low income tied to mortality risk after STEMI hospitalization

May 22 ,2022

Overview:ATLANTA — Patients with low household income who presented with STEMI faced greater risk for inpatient mortality, longer hospital stay and need for invasive mechanical ventilation vs. patients with higher income, a speaker reported here.At the Society for Cardiovascular Angiography and Interventions Scientific Sessions, Abdul Mannan Khan Minhas, MD, a hospitalist at Hattiesburg Clinic Hospital Care Service in Mississippi, presented findings that individuals in the lowest quartile of household income experienced worse outcomes after STEMI compared with those in the highest quartile.“These more

Ozanimod produces favorable long-term cardiac safety profile in UC, MS

May 21 ,2022

Overview:SAN DIEGO — Minimal long-term cardiac safety findings were reported with ozanimod treatment in patients with ulcerative colitis and relapsing multiple sclerosis, according to research presented at Digestive Disease Week 2022.“Ozanimod is a newly approved, oral sphingosine-1-phosphate (S1P) receptor modulator that specifically targets S1P1 and S1P5 and prevents lymphocyte migration to the intestines. It's approved in the U.S. and in Europe for the treatment of moderately to severely active UC as well as relapsing multiple sclerosis,” Millie Dascomb Long, MD, MPH, of the more

Decline in PCI for STEMI yet to return to pre-pandemic levels

May 21 ,2022

Overview:ATLANTA — The monthly rate of PCI for STEMI dropped steadily at the start of the COVID-19 pandemic and has yet to return to pre-pandemic levels, according to a speaker.At the Society for Cardiovascular Angiography and Interventions Scientific Sessions, Manoj Thangam, MD, interventional cardiologist at Ascension Texas Cardiovascular in Austin, Texas, presented data showing that monthly PCI for STEMI decreased by 39 procedures per month on average across 42 sites in the Ascension health system since March 2020.An analysis presented at the 2021 SCAI Scientific Sessions showed a significant more

Long-term clopidogrel confers less MACCE, bleeding events vs. aspirin after PCI

May 20 ,2022

Overview:ATLANTA — Clopidogrel monotherapy after 12 months of event free post-PCI dual antiplatelet therapy was associated with fewer MACCE and bleeding events vs. aspirin monotherapy in high bleeding risk patients, a speaker reported.Data presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions, showed that, at 30 months post-PCI, patients taking the P2Y12 inhibitor clopidogrel, as monotherapy experienced nearly half the risk for all-cause death, MI, definite/probable stent thrombosis, stroke or Bleeding Academic Research Consortium type 2, 3 or 5 bleeding more


May 20 ,2022

Overview:Vupanorsen (Ionis) for reduction of non-HDL in patients with hyperlipidemia already on statin therapy. more


May 20 ,2022

Overview:Electronic health record-based alert informing providers about evidence-based medications for HFrEF vs. usual care in outpatient clinics. more


May 20 ,2022

Overview:Tranexamic acid vs. placebo for life-threatening, major and critical organ bleeding in patients undergoing noncardiac surgery. more


May 20 ,2022

Overview:Ablation vs. standard care after first ICD shock for ventricular tachycardia. more


May 20 ,2022

Overview:Effects of alirocumab (Praluent, Sanofi/Regeneron) on coronary atherosclerosis in patients with acute MI undergoing PCI. more


May 20 ,2022

Overview:Influenza vaccine or placebo in patients with HF. more


May 20 ,2022

Overview:Sodium thiosulfate before and after STEMI for ischemia/reperfusion injury. more

From ‘disruptive technology’ to standard of care: Celebrating 20 years of TAVR

May 20 ,2022

Overview:This year marks 2 decades since the first transcatheter aortic valve replacement procedure was performed on an inoperable patient with severe symptomatic aortic stenosis — a historic moment that would change interventional cardiology.In the years since, TAVR, also referred to as transcatheter aortic valve implantation, or TAVI, has moved from a curiosity that drew excited crowds to become the standard of care for patients with symptomatic heart disease due to severe native calcific aortic stenosis. Procedural expertise and equipment have markedly improved; subsequent clinical trials more


May 20 ,2022

Overview:Diltiazem vs. placebo for coronary vasomotor dysfunction in patients with angina and nonobstructive CAD. more

No-implant interatrial shunt improves HF symptoms with durability at 1 year

May 20 ,2022

Overview:ATLANTA – A no-implant interatrial shunt improved HF symptoms including exercise capacity, quality of life and NYHA class at 3 and 6 months, a speaker reported.At the Society for Cardiovascular Angiography and Interventions Scientific Sessions, Colin M. Barker, MD, FSCAI, director of the cardiac catheterization laboratory at Vanderbilt University Medical Center in Nashville, Tennessee, presented multicenter data from three trial programs assessing the no-implant interatrial shunt (Alleviant Medical) for relief of HF symptoms: ALLEVIATE-HF-1, ALLEVIATE-HF-2 and ALLEVIATE HFrEF.According more

Impact of COVID-19 lockdown on STEMI admissions ‘substantial,’ driving poorer outcomes

May 20 ,2022

Overview:Delaying or stopping STEMI treatment during the first COVID-19-related lockdown in England was associated with approximately 2 life-years lost per patient vs. pre-lockdown conditions, according to a modeling analysis presented at EuroPCR.In an analysis to predict the potential clinical and economic burden associated with reductions in PCI treatment access during the COVID-19 lockdown in England, researchers said the difference was primarily driven by the reduced hospitalization rate at the start of lockdown and by a higher mortality rate in the long term for untreated survivors.“We more

Sheehan’s syndrome in GH-naive women may increase CV risk

May 20 ,2022

Overview:SAN DIEGO — Women with Sheehan’s syndrome and growth hormone deficiency have higher total cholesterol and triglycerides and higher inflammatory markers compared with healthy adults, according to a speaker.Sheehan’s syndrome is a postpartum hypopituitarism caused by ischemic necrosis of the pituitary gland after extreme hypotension or shock following severe hemorrhaging at childbirth, according to Rajaram Karne, MD, a clinical endocrinologist at the Veterans Affairs Medical Center in Columbus, Ohio. Severe GH deficiency is a common feature in women with Sheehan’s more

Long-term cardiovascular risk trajectory predicts cognitive decline, dementia

May 19 ,2022

Overview:Cumulative cardiovascular risk is a significant factor in determining the risk for cognitive decline and dementia, according to a study published in Neurology.“While vascular dementia de facto results from vascular injury, recent evidence has also implicated the role of cardiovascular factors in the progression of [Alzheimer’s disease],” Bryn Farnsworth von Cederwald, PhD, of the department of integrative medical biology at Umea University in Sweden, and colleagues wrote. “Notably, approximately 80% of patients diagnosed with AD exhibit vascular pathology when more

IV lithotripsy safe, effective for moderate to severe PAD calcification at 1 year

May 19 ,2022

Overview:ATLANTA — In patients with calcified peripheral artery disease undergoing drug-coated balloon treatment, preparing the vessel with IV lithotripsy conferred better 1-year outcomes vs. preparing it with percutaneous transluminal angioplasty.Results indicated that use of IV lithotripsy (Shockwave IVL, Shockwave Medical) to facilitate endovascular treatment of patients with moderately to severely calcified femoropopliteal arteries conferred better 1-year freedom from clinically driven target lesion revascularization and restenosis compared with use of percutaneous transluminal angioplasty more

Distal artery access PCI safe; no greater risk to hand function vs. proximal access

May 19 ,2022

Overview:ATLANTA — Thirty-day hand function did not differ following distal radial artery access compared with proximal radial access PCI, researchers reported.According to the results of the DIPRA trial presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions, distal radial artery access is a safe alternative to proximal access in PCI with a low complication rate and no increased risk for hand dysfunction at 30 days."Distal radial artery access is a safe strategy for access for cardiac catheterization with a low complication rate; a similar rate of success more

Optimal Antiplatelet Therapy In NSTE-ACS: Results From A Novel Crowdsourcing Survey

July 07 ,2021

Overview:The choice and duration of antiplatelet therapy in NSTE-ACS undergoing PCI is complex and is a hotly debated topic – particularly amongst patients at high bleeding risk. To gain insight into the real-world practices of a global cross-section of cardiologists, Radcliffe Medical Education, in partnership with the International Society of Cardiovascular Pharmacotherapy (ISCP), undertook a novel […] more

Results of an international crowdsourcing survey on the utilisation of antiplatelet therapy in NSTE-ACS

June 09 ,2021

Overview:Choosing an antiplatelet strategy in patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS) at high bleeding risk (HBR), undergoing percutaneous coronary intervention (PCI), is complex given that one must balance the risk of thrombosis with bleeding events. Since the most recent European guidelines were published in 2020, a number of important original research articles […] more

Hello world!

February 04 ,2021

Overview:Welcome to WordPress. This is your first post. Edit or delete it, then start writing! The post Hello world! appeared first on World Heart Federation. more

ACC.20/WCC Virtual continues!

April 05 ,2020

Overview:The World Heart Federation and American College of Cardiology held their first ever virtual congress March 28-30. But it’s not over. All of the ACC.20/WCC Virtual live sessions are now available on demand, along with additional videos, abstracts and slides — all for FREE. This includes Late-Breaking Clinical Trials, Featured Clinical Research, Young Investigator Awards, Keynotes, and more. All content will […] more

2020 ISCP Annual Meeting cancelled

February 26 ,2020

Overview:Notice of Cancellation We regret to have to inform our colleagues and friends that the 2020 ISCP Annual Scientific Meeting in Miami will now be cancelled. The Board of Directors of ISCP was forced to take the decision based on advice from different sources raising concern about the threat posed by the Covid-19 virus which […] more

European Cardiology Review (ECR) now on PubMed and PubMed Central

October 30 ,2018

Overview:    European Cardiology Review (ECR) confirms that it has been accepted for indexing on PubMed Central and PubMed. All ECR articles starting from the first issue in July 2014, will now be published online in full on PubMed Central, providing greater access for our authors’ articles amongst the global cardiology community. ECR is a […] more

WHF to attend the WHO Executive Board meeting in January 2017

January 23 ,2017

Overview:From 23 January to 01 February 2017, the World Health Organization(WHO) will host the 140th session. From 23 January to 01 February 2017, the World Health Organization(WHO) will host the 140th session. From 23 January to 01 February 2017, the World Health Organization(WHO) will host the 140th session. From 23 January to 01 February 2017, […] more